CTVACorteva
Is the business good?
The checks split: 6 of 9 health tests passed and returns not propped up by debt.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
A balanced mix of margins, efficiency, and leverage. ROE 5% = margin × turnover × leverage.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is CTVA?
Corteva keeps 5.7% of every revenue dollar as profit after everything, against 3.2% for the median Agricultural Inputs name.
Net margin · Agricultural Inputs median 3.2% · 12 months to Q2 2026
- Share count, year on year
- −1.9%
Share count, year on year · bought back, each share owns more of the company
- R&D as % of revenue
- 8.4%
R&D as % of revenue
- Gross margin
- 50%
Gross margin
Details›
- Gross margin12 months to Q2 2026
- 50%
- Net margin12 months to Q2 2026
- 5.7%
- Free cash flow margin
- 3.5%
- R&D as % of revenue
- 8.4%
- Revenue, trailing twelve months
- $17.8B
- Free cash flow, trailing twelve months
- $629M
- Net income, trailing twelve months
- $1.01B
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Basic Materials
Ranks #96 of 179 by RyuScore